Lighthouse Investment Partners’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
Lighthouse Investment Partners's RNAM Position: Q1 2026 in Review
Lighthouse Investment Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 41,985 shares — an estimated $3.03M sold.
Lighthouse Investment Partners first reported a position in RNAM in Q4 2023 and held it in 2 quarters. The position peaked at $3.03M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Lighthouse Investment Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Lighthouse Investment Partners sold 41,985 Avidity Biosciences shares in Q1 2026, an estimated $3.03M.
- Lighthouse Investment Partners first reported a position in Avidity Biosciences in Q4 2023 and held it in 2 quarters.
- Lighthouse Investment Partners's Avidity Biosciences position peaked at $3.03M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.